Claudio Picariello
Overview
Explore the profile of Claudio Picariello including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
85
Citations
506
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Enea I, Vedovati M, Scelsi L, Garascia A, Caravita S, Picariello C
G Ital Cardiol (Rome)
. 2025 Feb;
26(3):195-204.
PMID: 39998349
Background: Follow-up management of patients with pulmonary embolism (PE) is crucial to reduce the risk of recurrence and the early identification of those who develop pulmonary hypertension. However, this pathway...
2.
Vatrano M, Manzi G, Picariello C, DAlto M, Enea I, Ghio S, et al.
G Ital Cardiol (Rome)
. 2024 Feb;
25(3):192-201.
PMID: 38410902
Pulmonary hypertension (PH) is a frequent pathological condition worldwide, mainly secondary to cardiovascular and respiratory diseases, with a poor prognosis. Pulmonary arterial hypertension (PAH) is a rare form that affects...
3.
Caravita S, Gori M, Garascia A, Baratto C, Camassa N, Carigi S, et al.
G Ital Cardiol (Rome)
. 2024 Jan;
25(2):88-97.
PMID: 38270364
Pulmonary hypertension (PH) is a common complication of diseases affecting the left heart, mostly found in patients suffering from heart failure. Left atrial hypertension is the initial driver of post-capillary...
4.
Becattini C, Agnelli G, Diamanti M, Maggioni A, Vanni S, Dentali F, et al.
Vascul Pharmacol
. 2023 Nov;
153:107245.
PMID: 38013135
Introduction: Availability of new treatment strategies for patients with acute pulmonary embolism (PE) have changed clinical practice with potential influence in short-term patients' outcomes. We aimed at assessing contemporary anticoagulation...
5.
Gatto M, Oliva A, Palazzolo C, Picariello C, Garascia A, Nicastri E, et al.
Biomedicines
. 2023 May;
11(5).
PMID: 37238955
Pulmonary embolism (PE) has been associated with SARS-CoV-2 infection, and its incidence is highly variable. The aim of our study was to describe the radiological and clinical presentations, as well...
6.
Picariello C, Garascia A, Giordana F, Giudice F, Romaniello A, Vedovati M, et al.
G Ital Cardiol (Rome)
. 2023 Mar;
24(4):275-284.
PMID: 36971171
Patients with pulmonary embolism are a heterogeneous population and, after the acute phase and the first 3-6 months, the main issue is whether to continue, and hence how long and...
7.
Cutolo A, Frigo G, Picariello C, Themistoclakis S
G Ital Cardiol (Rome)
. 2022 Dec;
23(12):907-910.
PMID: 36504207
No abstract available.
8.
Rigatelli G, Zuin M, Picariello C, Gianese F, Pastore G, Baracca E, et al.
Turk Kardiyol Dern Ars
. 2022 Jul;
50(5):401.
PMID: 35860895
No abstract available.
9.
Caravita S, Picariello C, Garascia A, Misuraca L, De Tommasi E, Imbalzano E, et al.
G Ital Cardiol (Rome)
. 2022 Jun;
23(7):533-541.
PMID: 35771019
The discrimination between heart failure with preserved ejection fraction (HFpEF) and pulmonary arterial hypertension (PAH) requires a multiparametric approach, eventually culminating in right heart catheterization. Solving this differential diagnosis is...
10.
Rigatelli G, Zuin M, Picariello C, Gianese F, Pastore G, Baracca E, et al.
Turk Kardiyol Dern Ars
. 2022 Jun;
50(4):256-263.
PMID: 35695361
Objective: Incidence and prognostic value of new-onset atrial fibrillation after single versus double stent strategy in bifurcation left main disease has not been yet investigated. Methods: We retrospectively analyzed the...